Janssen Owes Family $10M In Topamax Suit, Jury Says

Law360, Los Angeles (November 18, 2013, 9:45 PM EST) -- A Philadelphia state jury decided on Monday that Janssen Pharmaceuticals Inc. is obligated to pay more than $10 million to the parents of a child who allegedly suffered birth defects due to the company's epilepsy drug Topamax, according to attorneys for the family.

The jury determined that the Johnson & Johnson unit didn't sufficiently warn doctors about the risk of birth defects stemming from the use of the drug, plaintiffs' counsel said. The company allegedly knew about the risks years before the drug was prescribed to...
To view the full article, register now.